Image

Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS

Study tests VNX001 for bladder pain compared to Lidocaine, Heparin, or placebo.

Recruiting
18 years and older
All
Phase 2

Study Overview: This study is testing a new medicine called VNX001 to see if it helps reduce bladder pain in people with a condition called interstitial cystitis/bladder pain syndrome (IC/BPS). VNX001 combines two existing medicines, lidocaine (a numbing medicine) and heparin (a blood thinner). The study will compare VNX001 to its parts and a placebo, which is a substance that looks like medicine but doesn't do anything. A total of 120 to 180 people from around the United States will participate.

Eligibility: To join, you must be 18 or older, have had IC/BPS for at least nine months, and have moderate to severe bladder pain. You cannot join if you are pregnant, have allergies to lidocaine or heparin, take certain medications, or have other medical conditions that might interfere with the study.

  • The study involves a single dose and possibly a follow-up dose of VNX001.
  • Participants might receive a placebo, VNX001, or its parts randomly.
  • There are certain health conditions and medications that can prevent participation.

If interested, discuss with your doctor to see if this study is right for you.

Study details
    Interstitial Cystitis
    Bladder Pain Syndrome

NCT05737121

Vaneltix Pharma, Inc.

16 March 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.